These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8080696)

  • 1. Effect of overall time and dose on the response of glottic carcinoma of the larynx to radiotherapy.
    Fowler JF; Chappell R
    Eur J Cancer; 1994; 30A(5):719-21. PubMed ID: 8080696
    [No Abstract]   [Full Text] [Related]  

  • 2. Elevated plasma CEA during radiotherapy for glottic carcinoma of the larynx.
    Jakobsson PA; Wahren B
    Can J Otolaryngol; 1975; 4(1):46-50. PubMed ID: 1131725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dose-time-volume factors in radiotherapy of T2N0M0 glottic cancer].
    Kagami Y; Nishiyama K; Ikeda H; Masaki N; Shigematsu Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1983 Oct; 43(10):1194-8. PubMed ID: 6672748
    [No Abstract]   [Full Text] [Related]  

  • 4. Electron beam treatment of early glottic lesions.
    Soni SC; Khan FR; Ovadia J; Nickson JJ
    J Radiol Electrol Med Nucl; 1974; 55(6-7):481-3. PubMed ID: 4214457
    [No Abstract]   [Full Text] [Related]  

  • 5. Radiotherapy in early glottic carcinoma.
    Kanonier G; Fritsch E; Rainer T; Thumfart WF
    Ann Otol Rhinol Laryngol; 1996 Oct; 105(10):759-63. PubMed ID: 8865769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relation between overall treatment time and local control of early glottic laryngeal cancer: comparison of six versus five times per week].
    Kitano M; Nishiguchi I; Aoki Y; Nakayama M; Nagai H; Takahashi H; Okamoto M; Matsubayashi T; Hayakawa K
    Nihon Igaku Hoshasen Gakkai Zasshi; 2002 Jun; 62(7):366-9. PubMed ID: 12136637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definitive radiation management for carcinoma of the glottic larynx.
    Moose BD; Greven KM
    Otolaryngol Clin North Am; 1997 Feb; 30(1):131-43. PubMed ID: 8995141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of underdosage in the external photon beam radiotherapy of glottic carcinoma: Monte Carlo study.
    Spirydovich S; Papiez L; Moskvin V; Desrosiers P
    Radiother Oncol; 2006 Feb; 78(2):159-64. PubMed ID: 16360226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early-stage glottic cancer: importance of dose fractionation in radiation therapy.
    Kim RY; Marks ME; Salter MM
    Radiology; 1992 Jan; 182(1):273-5. PubMed ID: 1727295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moderate-dose radiotherapy for glottic cancer.
    JAMA; 1979 Nov; 242(22):2382. PubMed ID: 490841
    [No Abstract]   [Full Text] [Related]  

  • 11. Intensity-modulated radiation therapy reduces the dose to normal tissue in T2N0M0 squamous cell carcinoma of the glottic larynx.
    Peñagarícano JA; Ratanatharathorn V; Papanikolaou N; Yan Y
    Med Dosim; 2004; 29(4):254-7. PubMed ID: 15528066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical assessment of tumor clearance during radiotherapy as a prognostic factor of early glottic carcinoma.
    Inoue T; Inoue T; Ikeda H; Teshima T; Murayama S
    Strahlenther Onkol; 1992 Oct; 168(10):579-83. PubMed ID: 1440229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tumor response and local control after radiation therapy of T1N0M0 glottic carcinoma].
    Inoue T; Inoue T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1983 Dec; 43(12):1376-81. PubMed ID: 6674929
    [No Abstract]   [Full Text] [Related]  

  • 14. Significance of pretreatment hemoglobin level in patients with T1 glottic cancer.
    Canaday DJ; Regine WF; Mohiuddin M; Zollinger W; Machtay M; Lee J; Schultz D; Rudoltz MS
    Radiat Oncol Investig; 1999; 7(1):42-8. PubMed ID: 10030623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late local recurrence after radiotherapy for tongue and early glottic carcinoma.
    Inoue T; Inoue T; Teshima T; Murayama S; Nose T; Tanaka E; Yamazaki H; Koizumi M; Kagawa K; Ozeki S; Ikeda H
    Strahlenther Onkol; 1996 Jun; 172(6):301-5. PubMed ID: 8677501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment decisions in T3N0M0 glottic carcinoma.
    Bryant GP; Poulsen MG; Tripcony L; Dickie GJ
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):285-93. PubMed ID: 7836082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [T1a glottic neoplasms: experience with surgery and radiotherapy].
    Nicolai P; Bovarini M; Bonfioli F; Bonetti B; Moretti R; Magno L; Antonelli AR
    Acta Otorhinolaryngol Ital; 1988; 8(6):581-90. PubMed ID: 3247844
    [No Abstract]   [Full Text] [Related]  

  • 18. Radiation therapy for glottic cancer using 6-MV photons.
    Beitler JJ; Yaes RJ; Lai PP; Vikram B
    Cancer; 1996 Jul; 78(1):183-4. PubMed ID: 8646719
    [No Abstract]   [Full Text] [Related]  

  • 19. Anterior commissure carcinoma. Primary treatment with radiotherapy in 57 patients.
    Olofsson J; Williams GT; Rider WD; Bryce DP
    Arch Otolaryngol; 1972 Mar; 95(3):230-3 passim. PubMed ID: 5013267
    [No Abstract]   [Full Text] [Related]  

  • 20. Carotid sparing intensity-modulated radiation therapy achieves comparable locoregional control to conventional radiotherapy in T1-2N0 laryngeal carcinoma.
    Zumsteg ZS; Riaz N; Jaffery S; Hu M; Gelblum D; Zhou Y; Mychalczak B; Zelefsky MJ; Wolden S; Rao S; Lee NY
    Oral Oncol; 2015 Jul; 51(7):716-23. PubMed ID: 25958831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.